Case Western Reserve University

Nottingham Spirk Design Associates is one of the leading new product invention and development groups in the United States. The company has invented and designed several products and packaging and promotional programs since 1972. With annual sales revenue of more than $30 billion, the company holds over 500 commercialized patents. Nottingham Spirk Design Associates serves the automotive, chemical, electronics, medical and engineering sectors. It has expertise in the areas of engineering, feasibility testing, global sourcing, market research and intellectual property development. The company provides competitive analysis, prototyping, corporate branding, quality assurance and structural packaging services. Nottingham Spirk Design Associates maintains product testing and designing facilties.

Kordalski Architects, based in Cleveland, OH, showcases two decades of diverse project types ranging from small to large-scale designs, all unified by a commitment to exceptional design quality. Their portfolio features completed project photos, along with conceptual sketches and models, providing insight into their creative process and design exploration. The firm believes that design matters significantly, highlighting their work through brief project descriptions accompanied by jury comments, which underline the esteem of their projects among respected professionals in the field. This emphasis on professional recognition speaks to the caliber and thoughtful approach that Kordalski Architects consistently brings to every project. Generated from the website

Cleveland HeartLab, Inc. is a leading provider of diagnostic services specializing in cardiometabolic disorders. As the base for Quest's first national center of excellence in this field, Cleveland HeartLab offers innovative blood and urine biomarkers that provide a comprehensive assessment of cardiovascular risk. Their collaboration with Cleveland Clinic allows them to offer diagnostic services based on cutting-edge research in inflammation and other areas of medicine. With a focus on innovation, education, and clinical references, Cleveland HeartLab is committed to advancing the understanding and identification of cardiovascular risk. Their research and development program, in partnership with renowned academic and medical institutions, brings unique biomarker technologies to the market. By measuring inflammation levels and utilizing a multi-marker approach, they aim to uncover hidden risks that may be missed by standard lipid testing, ultimately helping patients and physicians nationwide in the prevention and management of heart disease.Generated from the website